Stratos Genomics
Total Raised
$53.2MInvestors Count
5Deal Terms
2Stratos Genomics Funding, Stratos Genomics Valuation & Stratos Genomics Revenue
8 Fundings
Stratos Genomics's latest funding round was a Acquired for on May 22, 2020.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
5/22/2020 | Acquired | 4 | ||||
1/8/2018 | Series C | |||||
6/16/2015 | Series B - III | |||||
6/26/2014 | Corporate Minority | |||||
9/6/2013 | Series B - II |
Date | 5/22/2020 | 1/8/2018 | 6/16/2015 | 6/26/2014 | 9/6/2013 |
---|---|---|---|---|---|
Round | Acquired | Series C | Series B - III | Corporate Minority | Series B - II |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 4 |
Stratos Genomics Deal Terms
2 Deal Terms
Stratos Genomics's deal structure is available for 2 funding rounds, including their Series B from October 16, 2012.
Round | Series B | Series A |
---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Stratos Genomics Investors
5 Investors
Stratos Genomics has 5 investors. Roche Holding invested in Stratos Genomics's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
6/26/2014 | 5/22/2020 | 2 Corporate Minority, Acquired (2020) | Holding Company | Switzerland | ||
Venture Capital | New York | |||||
Corporate Venture | Switzerland | |||||
Venture Capital | Massachusetts | |||||
Other | New Jersey |
First funding | 6/26/2014 | ||||
---|---|---|---|---|---|
Last Funding | 5/22/2020 | ||||
Investor | |||||
Rounds | 2 Corporate Minority, Acquired (2020) | ||||
Board Seats | |||||
Type | Holding Company | Venture Capital | Corporate Venture | Venture Capital | Other |
Location | Switzerland | New York | Switzerland | Massachusetts | New Jersey |
You May Also Like
ACGT develops genomics-based solutions that increase productivity and enhance value creation from the oil palm and other oil crops. It is based in Kuala Lumpur, Malaysia.

Omixon is a global molecular diagnostics company that commercializes technologies for clinical and research laboratories. Omixon's flagship product, Holotype HLA, is an NGS-based HLA genotyping product that delivers high-resolution HLA genotyping. Omixon's research software, HLA Explore, analyzes data from any sequencing technology and determines HLA genotypes from whole exome/genome sequencing experiments.

Aperiomics identifies bacteria, viruses, fungi, and parasites through Deep Shotgun Metagenomic Sequencing, using its database of microbes. The company helps doctors and their patients identify the causes of infections that other tests cannot identify, thus streamlining the path to a positive clinical outcome.
Sequentia Biotech is a bioinformatics company that transforms omics data into knowledge. The company offers bioinformatics cloud softwares, custom softwares and bioinformatics consulting services for healthcare, pharma, agriculture, industry and the environment.

CJ Bioscience (KOSDAQ: 311690) is a bioinformatics company that develops data-driven microbiome therapeutics solutions for the microbiology sector. The company's suite of tools includes EzBioCloud, a database for academic research and commercial development, and BIOiPLUG, a cloud-based bioinformatics and analysis platform. It was founded in 2009 and is based in Seoul, South Korea.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.